FDA Import Refusal DSV-3850625-6/31/1 — Gland Pharma Limited
The FDA refused shipment DSV-3850625-6/31/1 from Gland Pharma Limited (India) on July 8, 2024. The refused product falls under Drugs and Biologics — HEPARIN SODIUM (ANTI-COAGULANT). Cited charge: 115 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 8, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61LCP08 HEPARIN SODIUM (ANTI-COAGULANT)
- Charges
- 115